News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Netan Choudhry, MD

Advertisement

Articles by Netan Choudhry, MD

The subthreshold laser’s role in retinal vascular disease

ByNetan Choudhry, MD
October 18th 2018

Combination therapy benefits from laser in the mix for DME, other conditions

Advertisement

Latest Updated Articles

  • The subthreshold laser’s role in retinal vascular disease
    The subthreshold laser’s role in retinal vascular disease

    Published: October 18th 2018 | Updated:



Advertisement
Advertisement

Trending on Modern Retina

1

AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives

2

AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care

3

Prevent Blindness delegates first week of December as 5th annual geographic atrophy week

4

EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada

  • About
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us